Ikarian Capital, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value (AVTX)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value
Symbol: AVTX
Shares outstanding: 11.9M shares
Disclosed Ownership: 1.19M shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 17:33:21 UTC
Date of event: 31 Mar 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	9.99%	1.19M	0	1.19M	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	9.99%	1.19M	0	1.19M	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager